CME
- How and When to Consider a PCSK9 Inhibitor in Practice
- Cardiovascular and Respiratory Disease Summit (CARPS)
- Cardiovascular and Respiratory Disease Summit (CARPS) 2019
- Case Challenges in Clinical Use of PCSK9 Inhibitors
- Can We Do It Better: Managing Atrial Fibrillation in Patients with Structural Heart Disease
- Best Practices in Prostacyclin Therapy for Pulmonary Arterial Hypertension in the Hospitalized Patient